Zurueck zur Suche

Reporte zur Charge U006312

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

13Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 6 UT 3 ID 1 ND 1 WA 1 OR 1

VAERS 1760014

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U006312

schwer
Staat
CA
Alter
6,0
Geschlecht
M
Eingang
04.10.2021
Impfdatum
28.09.2021
Beginn
29.09.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Increased tendency to bruise Pyrexia Rash macular Seizure Skin lesion

Symptomtext

Mother called 2 to 3 days after the vaccine indicating that patient had had fever of 103 Fahrenheit in addition to lacy rash with macules throughout upper and lower extremities. Mother also reported a seizure activity at home. Patient was not brought into the clinic nor were they brought into urgent care or emergency room. PCP was told days after the event. Patient doing well at home though continues to be fatigued with new lesions on upper and lower extremities per parent. Patient also having these macules around eyes however no conjunctivitis per parent. Patient is approximately almost 1 week out with these ongoing lesions and fatigue. Mother reports also easy bruising. Patient being treated conservatively at home use of Tylenol only for fevers. Mother has refused to take the patient to urgent care or to bring to the clinic for evaluation. We will continue to follow-up with patient in the next week.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
None
Allergien
none
Vorherige Impfungen
-

VAERS 1821496

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U006312

mild
Staat
CA
Alter
6,0
Geschlecht
F
Eingang
27.10.2021
Impfdatum
25.10.2021
Beginn
26.10.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Injection site vesicles Swelling

Symptomtext

Localized swelling and erythema, numerous clear vesicles (<50) localized to injection site

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site vesicles
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1750239

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U006312

mild
Staat
ID
Alter
4,0
Geschlecht
M
Eingang
30.09.2021
Impfdatum
30.09.2021
Beginn
30.09.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash Urticaria

Symptomtext

Child developed facial hives approximately 3 hours after vaccine administration. Advised to administer Benadryl Q6 hours and call office tomorrow if not resolved. Seek emergency care if oral/throat swelling or difficulty breathing occurs.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Exposure to hand, foot and mouth and subsequent fever and sore throat about a week prior to vaccines
Vorgeschichte
History of Lyme disease, psoriasis
Andere Medikamente
Pediatric chewable vitamin with iron, econazole ointment
Allergien
None known
Vorherige Impfungen
-

VAERS 2610481

GLAXOSMITHKLINE BIOLOGICALS · DTAP + IPV (KINRIX) · Charge U006312

gering
Staat
CA
Alter
4,0
Geschlecht
F
Eingang
03.04.2023
Impfdatum
09.08.2021
Beginn
09.08.2021
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

No adverse reaction to report, However pt was given an additional dose of MMRV and DtaP:IPV. Pt has just received them on 7/28/21, and received them again.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
none
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2469169

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge u006312

gering
Staat
UT
Alter
-
Geschlecht
U
Eingang
05.10.2022
Impfdatum
06.09.2022
Beginn
06.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs were reported.; Medical assistant reported that an expired PROQUAD was administered to a patient.; This spontaneous report was received from medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 06-SEP-2022, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, albumin status: rHA (recombinant Human albumin) 1 dose, lot #u006312, expiration date: 24-AUG-2022 for prophylaxis (dose, route of administration and anatomical location were not provided) with sterile diluent (MERCK STERILE DILUENT) solution for injection/infusion (expired product administered). No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
MERCK STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2072522

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U006312

gering
Staat
UT
Alter
17,0
Geschlecht
F
Eingang
28.01.2022
Impfdatum
27.12.2021
Beginn
27.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

Proquad given to 17 year old for needed vaccination of Measles, Mumps, Rubella and Varicella. Patient presented with no previous immunizations and was starting all vaccinations from the start. Proquad was given by mistake, age requirement for proquad was missed. No adverse reaction, so no treatment was needed, patient did not show any signs or symptoms of distress or any kind of reaction. Patient left clinic without issue or concern.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 1962786

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U006312

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
20.12.2021
Impfdatum
10.11.2021
Beginn
10.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event Product preparation issue

Symptomtext

No additional adverse events (AEs) or product compliant (PQC) were reported.; expired Merck Sterile Diluent used to reconstitute vaccine that was administered; expired Merck Sterile Diluent used to reconstitute vaccine that was administered; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant therapies and drug allergy or reactions were not reported. On 10-NOV-2021, expired sterile diluent (manufacturer unknown) (lot # S002625; expiration date: 09-NOV-2021) was used to reconstitute vaccine measles, mumps, rubella and varicella (oka-merck) virus vaccine live (albumin status recombinant Human albumin (rHA) (PROQUAD) (lot # U006312; expiration date: 24-AUG-2022; strength, dose and route were not reported) that was administrated to patient for prophylaxis (product preparation issue and expired product administered). No additional adverse events (AEs) or product compliant (PQC) were reported (no adverse event). This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-2112USA004629: US-009507513-2112USA004666: US-009507513-2112USA004424: US-009507513-2112USA004364: US-009507513-2112USA004666:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 1890725

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U006312

gering
Staat
UT
Alter
5,0
Geschlecht
M
Eingang
22.11.2021
Impfdatum
22.11.2021
Beginn
22.11.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Inappropriate schedule of product administration Wrong product administered

Symptomtext

Patient was given vaccine that he did not need. He had had Hep A #1 on 08/03/2021 and should come back in Feb 2022 for his second dose. I failed to recognize this and have him his second hep A 11/22/21. Patient was given Proquad 11/22/21. He had his 2nd MMR 08/03/2021 and did not need this. He did need his second varicella today-11/22/21. Quadracel was given. He had Quadracel 08/23/2021 for his 5th dtap and 4th polio. He did not need quadracel today. I explained to mom afterward that I made a mistake and that he should come back in Feb 2022 for his second Hep A. Mom was given a credit for his vaccines as she paid today. I had already told her side effects and symptoms with the assistance of the interpreter as well as what to watch for with an allergic reaction. I informed mom that these extra vaccines should not cause harm but to watch for side effects.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
no
Andere Medikamente
unknown
Allergien
no
Vorherige Impfungen
-

VAERS 1845759

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U006312

gering
Staat
CA
Alter
9,0
Geschlecht
U
Eingang
05.11.2021
Impfdatum
07.10.2021
Beginn
07.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered No adverse event

Symptomtext

No other AEs or PQC reported. No Additional information available.; received PROQUAD and VARlVAX at same visit; This spontaneous report was received from a medical assistant and refers to a 9-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 07-OCT-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) lot # U006312, expiration date 24-AUG-2022, 0.5 milliliter, subcutaneously (SQ) and varicella virus vaccine live (oka/merck) (VARIVAX) lot # U007471, expiration date 08-MAR-2023, 0.5 ml, SQ (formulations, concentrations, dose numbers and anatomical locations were not reported) for prophylaxis. Both the vaccines were administered at the same visit (overdose). No additional adverse event was reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1836359

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U006312

gering
Staat
ND
Alter
24,0
Geschlecht
F
Eingang
02.11.2021
Impfdatum
28.10.2021
Beginn
28.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

Patient came into the clinic for a MMR vaccine per her employer's request. The nurse took the MMR vaccine box out of the freezer and noticed that box was expired. She then grabbed the unopened box behind it, reconstituted the vaccine, educated the patient about the vaccine, and administered the dose to the patient. The patient left the clinic after the vaccine. While the nurse was entering the order into the computer system, she noticed she had given the wrong vaccine to the patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 1820358

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U006312

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
27.10.2021
Impfdatum
19.10.2021
Beginn
19.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; medical assistant who reports that one dose of PROQUAD was administered today (10/19/2021) following a temperature excursion; This spontaneous report was received from a medical assistant referring to patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 19-OCT-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot number U006312, expiration date 24-AUG-2022 (dose and route of administration not provided) for prophylaxis (product storage error). No adverse event was reported. The vaccine underwent a temperature excursion of 6.58 degrees Farhrenheit for 1 hour. No previous temperature excrusions reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1759051

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U006312

gering
Staat
CA
Alter
1,0
Geschlecht
M
Eingang
04.10.2021
Impfdatum
04.10.2021
Beginn
04.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event

Symptomtext

Patient tolerated vaccines well. No redness or swelling.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
No
Allergien
No
Vorherige Impfungen
-

VAERS 1657717

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U006312

gering
Staat
OR
Alter
1,0
Geschlecht
U
Eingang
31.08.2021
Impfdatum
24.08.2021
Beginn
24.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event Wrong product administered

Symptomtext

No additional adverse event reported; A 12 month old child was given PROQUAD instead of VARIVAX with the MMR II; A 12 month old child was given PROQUAD instead of VARIVAX; This spontaneous report has been received from a registered nurse concerning a 12 months old patient, gender not provided. Information regarding the patient's medical history, concurrent conditions and concomitant medications was not reported. On 24-AUG-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 1 dose, for prophylaxis (lot number U006312 has been determined to be valid for measles, mumps, rubella and varicella (oka-merck) virus vaccine live, expiration date reported and establish as 24-AUG-2022) instead of varicella virus vaccine live (oka/merck) (VARIVAX) (wrong product administered); on the same date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) 1 dose, for prophylaxis (lot number S035355 has been determined to be valid for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, expiration date reported and establish as 05-NOV-2021) (inappropriate schedule of product administration) (strength, route of administration and anatomical location were not provided). No adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-